This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2025 - Rare Disease Summit
March 18-20, 2025
Pre-Conference Workshops on March 17, 2025Sheraton Philadelphia Downtown | Philadelphia, PA

Karlie Sharma, Ph.D.
Program Director, Office of Drug Development Partnership Programs at National Center for Advancing Translational Sciences, National Institutes of Health
Speaker

Profile

Karlie Sharma is a program director in the Office of Drug Development Partnership Programs at the National Center for Advancing Translational Sciences at the NIH, where she serves as the lead for the NIH Common Fund-sponsored Illuminating the Druggable Genome (IDG) program. Building on the success of a small grant program she led in the IDG program, Sharma has established a rare disease R03 pilot project funding opportunity to enable exploration of understudied proteins purported to affect rare diseases. Sharma received her doctorate in molecular physiology and biophysics from Baylor College of Medicine in Houston, Texas.

Agenda Sessions

  • Funding Opportunities – A Discussion with Diverse Stakeholders

    2:15pm